Literature DB >> 15650804

Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.

Hiroyuki Yamashita1, Tom Cantor, Shinya Uchino, Shin Watanabe, Takahiro Ogawa, Taiki Moriyama, Yuji Takamatsu, Masafumi Fukagawa, Shiro Noguchi.   

Abstract

Most commercial assays for intact parathyroid hormone (iPTH) cross-react with non-PTH1-84 fragments (likely to be PTH7-84). We aimed to evaluate a whole PTH assay that measured only PTH1-84 by comparing it with an assay measuring iPTH levels during parathyroidectomy in secondary hyperparathyroidism (HPT). Twenty-eight patients with secondary HPT who underwent total parathyroidectomy with autotransplantation served as subjects. Blood samples for postoperative assay were drawn after anesthesia; immediately prior to excision of the last parathyroid gland; and at 5, 10, and 15 minutes after excision. The PTH7-84 level was calculated by subtracting the whole PTH value from the iPTH value. Plasma whole PTH decreased more rapidly than iPTH after parathyroidectomy (p < 0.0001). PTH levels that decreased by 50% or more from levels prior to excision to 10 minutes after excision were used to predict successful parathyroidectomy; decreases in whole PTH substantiated curative surgery for all patients without introducing false-positive and false-negative results. iPTH levels decreased by at least 50% in only 16 patients at 10 minutes after excision without false-positive results. Out of 11 cases in which iPTH decreased less than 50%, two were true-negatives and nine were false-negatives. Decreases in whole PTH levels more accurately reflect surgical outcome than do decreases in iPTH levels during parathyroidectomy in secondary HPT patients. Even though the quick iPTH assay is used infrequently during surgery for secondary HPT, our results suggest that a quick whole PTH assay may be more useful than the iPTH assay currently used in parathyroidectomy procedures for secondary HPT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650804     DOI: 10.1007/s00268-004-7489-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

1.  Reoperation for renal hyperparathyroidism.

Authors:  Yatsuka Hibi; Yoshihiro Tominaga; Tetsuhiko Sato; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Toshihiro Ichimori; Masahiro Numano; Yuji Tanaka; Hiroshi Takagi; Tsuneo Imai; Hiroomi Funahashi; Akimasa Nakao
Journal:  World J Surg       Date:  2002-09-04       Impact factor: 3.352

2.  Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism.

Authors:  S K Libutti; H R Alexander; D L Bartlett; M L Sampson; M E Ruddel; M Skarulis; S J Marx; A M Spiegel; W Simmonds; A T Remaley
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

3.  Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease.

Authors:  C A Proye; A Goropoulos; C Franz; B Carnaille; M Vix; J L Quievreux; G Couplet-Lebon; A Racadot
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

4.  Minimal-access parathyroid surgery using intraoperative parathyroid hormone assay.

Authors:  R A Sofferman; J Standage; M E Tang
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

5.  Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism.

Authors:  B M Clary; S C Garner; G S Leight
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

6.  Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.

Authors:  J H Brossard; M Cloutier; L Roy; R Lepage; M Gascon-Barré; P D'Amour
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

7.  Intraoperative parathormone level measurement in the management of hyperparathyroidism.

Authors:  C R McHenry; A Pollard; P G Walfish; I B Rosen
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

8.  A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

Authors:  M R John; W G Goodman; P Gao; T L Cantor; I B Salusky; H Jüppner
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

9.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

10.  Intraoperative and postoperative PTH secretion mode in patients with hyperparathyroidism.

Authors:  S Fischer; D Flentje; C Kettelhack; J Schmidt-Gayk; H Buhr; C Herfarth
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more
  8 in total

1.  Will intra-operative measurement of parathyroid hormone alter the surgical concept of renal hyperparathyroidism?

Authors:  K Lorenz; H Dralle
Journal:  Langenbecks Arch Surg       Date:  2005-08       Impact factor: 3.445

2.  Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol.

Authors:  Kerstin Lorenz; Jörg Ukkat; Carsten Sekulla; Oliver Gimm; Michael Brauckhoff; Henning Dralle
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 3.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

4.  QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism.

Authors:  Susumu Matsuoka; Yoshihiro Tominaga; Tetsuhiko Sato; Nobuaki Uno; Norihiko Goto; Akio Katayama; Kazuharu Uchida; Hiroshi Takami
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

5.  The role of preoperative ultrasonography, computed tomography, and sestamibi scintigraphy localization in secondary hyperparathyroidism.

Authors:  Jae Bok Lee; Woo Young Kim; Yu-Mi Lee
Journal:  Ann Surg Treat Res       Date:  2015-11-27       Impact factor: 1.859

6.  The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM.

Authors:  Etienne Cavalier; Samuel Vasikaran; Harjit P Bhattoa; Annemieke C Heijboer; Konstantinos Makris; Candice Z Ulmer
Journal:  Clin Chim Acta       Date:  2021-01-04       Impact factor: 3.786

7.  Comparison between Second- and Third-Generation PTH Assays during Minimally Invasive Parathyroidectomy (MIP).

Authors:  Marie-Hélène Gannagé-Yared; Nada Younès; Anne-Sophie Azzi; Ghassan Sleilaty
Journal:  Int J Endocrinol       Date:  2020-03-16       Impact factor: 3.257

8.  Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism.

Authors:  Woo Young Kim; Jae Bok Lee; Hoon Yub Kim
Journal:  J Korean Surg Soc       Date:  2012-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.